Multiple Manufacturers

FIRAZYR

Manufacturer:

Multiple Manufacturers

Firazyr HCPCS:

J1744

HCPCS Code Descriptor:

Injection, icatibant, 1 mg

Category:

J Code

Firazyr NDCs:

69097-0664-34, 60505-6214-01, 00093-3066-34, 69097-0664-68, 24201-0207-01, 63323-0574-86, 00093-3066-93, 70709-0013-01, 54092-0702-02, 70709-0013-03, 63323-0574-93, 54092-0702-03, 55150-0351-03, 55150-0351-01

Primary Type:

Immunology

Generic/Specialty Status:

Multi-Source

Package Type:

Syringe

Route of Administration:

Subcutaneous

Firazyr CPT Codes:

Potential CPT administration codes for Firazyr can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

70709-0013-01

About Firazyr:

FIRAZYR is a medication manufactured by multiple manufacturers and aligned to the J Code: J1744. FIRAZYR is administered via the subcutaneous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J1744 Added Date:

January 1, 2013

J1744 Effective Date:

January 1, 2013

J1744 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Firazyr billing and coding information.
Our team did not identify a source for Firazyr patient assistance information. Please reach out to our team if you feel that this is a mistake.
FIRAZYR prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for FIRAZYR. Please check back in a few weeks.